Valganciclovir国内有卖吗？

The clinical antiviral effect of valganciclovir hydrochloride tablets () has been confirmed by treating AIDS patients with newly diagnosed retinitis (clinical study WV15376). After four weeks of treatment with valganciclovir hydrochloride tablets, the detection rate of CMV virus decreased from 46% (32/69) at study enrollment to 7% (4/55). Clinical studies of valganciclovir hydrochloride tablets in AIDS patients infected with CMV retinitis have shown that valganciclovir hydrochloride tablets and intravenous ganciclovir are equally effective in the induction treatment of CMV retinitis. In the study, patients with newly diagnosed CMV retinitis were randomly assigned to the valganciclovir hydrochloride tablet group or the intravenous ganciclovir group for induction therapy. The proportion of patients with progression of CMV retinitis at week four was the same in both groups. After induction therapy, both groups of patients in this study continued to receive maintenance therapy with valganciclovir hydrochloride tablets 900 mg per day. In patients who received induction therapy with valganciclovir or intravenous ganciclovir followed by maintenance therapy with valganciclovir, the mean (median) time from randomization to progression of CMV retinitis was 226 (160) days and 219 (125) days, respectively. Oral valganciclovir hydrochloride tablets can achieve similar body ganciclovir exposure levels when administered at recommended doses of intravenous ganciclovir, which is effective in the treatment of CMV retinitis.

The good news is that Valganciclovir hydrochloride tablets (Valganciclovir) are already on the market in China, and patients can buy them in large hospitals with a prescription. However, the price is extremely high, at 16,500$ per box, which is not as cost-effective as valganciclovir hydrochloride tablets (5,500$) in India. Patients can obtain it through domestic professional overseas medical service institutions.